Linc AB
Overview
Linc AB is a Swedish private equity firm specializing in investments within the Nordic life science sector, focusing on pharmaceutical and medical technology companies. The firm primarily invests in small and medium-sized enterprises, aiming to develop and support businesses with global potential. Linc's investment approach is characterized by active and long-term ownership, collaborating closely with management teams to realize the inherent potential of portfolio companies. The firm's investment strategy involves early-stage investments in drug development and more mature investments in medical technology. Linc typically invests between SEK 25 million and SEK 250 million (approximately $2.99 million to $29.99 million) in both private and public companies, as well as research and operational entities. This approach allows Linc to support a diverse range of companies within the life science industry. Linc's portfolio includes several notable companies, such as OncoZenge, FluoGuide, and Cinclus Pharma. The firm has a history of successful exits, demonstrating its ability to identify and nurture high-potential companies within the life science sector. Linc's commitment to active ownership and its extensive industrial network contribute to the growth and success of its portfolio companies.
Investment Focus
- Active and long-term ownership
- Collaboration with management teams
- Focus on life science sector
Portfolio Companies
Reach Linc AB directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Linc AB
What sectors does Linc AB invest in?
Linc AB invests in Pharmaceuticals, Biotechnology and Medical Technology, and is based in Stockholms Län, Sweden. Linc AB is listed as a private equity in the ConnectSafely investor database.
What stage does Linc AB invest at?
Linc AB backs companies at Early Stage, Growth and Late Stage, writing cheques of 3.0M - 30.0M.
Which regions does Linc AB invest in?
Linc AB invests across Denmark, Sweden, Norway, Finland and Iceland.
What companies has Linc AB invested in?
Linc AB's portfolio includes Cinclus Pharma, OncoZenge and FluoGuide.
How do I contact Linc AB?
Linc AB's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
